Functional SNP of ARHGEF10 confers risk of atherothrombotic stroke

Human Molecular Genetics

Volumn 19, Issue 6, 2010, Pages 1137-1146

  Matsushita, Tomonaga ^a,b   Ashikawa, Kyota ^a   Yonemoto, Koji ^b   Hirakawa, Yoichiro ^b   Hata, Jun ^b   Amitani, Hanae ^a   Doi, Yasufumi ^b   Ninomiya, Toshiharu ^b   Kitazono, Takanari ^b   Ibayashi, Setsuro ^b   Iida, Mitsuo ^b   Nakamura, Yusuke ^c   Kiyohara, Yutaka ^b   Kubo, Michiaki ^a,b  

^a RIKEN   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR 10; GUANOSINE TRIPHOSPHATASE; LUCIFERASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ADULT; ARTERY THROMBOSIS; ARTICLE; BINDING AFFINITY; BRAIN ISCHEMIA; CANCER CELL CULTURE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; GEL MOBILITY SHIFT ASSAY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INCIDENCE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

ALLELES; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CELL LINE, TUMOR; ENZYME ACTIVATION; EXONS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INCIDENCE; INTRONS; JAPAN; KAPLAN-MEIERS ESTIMATE; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RHOA GTP-BINDING PROTEIN; SP1 TRANSCRIPTION FACTOR; STROKE; THROMBOSIS; TRANSCRIPTION, GENETIC;

EID: 77950652900     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp582     Document Type: Article

References (32)

1. Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, D.T. and Murray, C.J. (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 367, 1747-1757.
2. Flossmann, E., Schulz, U.G. and Rothwell, P.M. (2004) Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke, 35, 212-227.
3. Ikram, M.A., Seshadri, S., Bis, J.C., Fornage, M., DeStefano, A.L., Aulchenko, Y.S., Debette, S., Lumley, T., Folsom, A.R., van den Herik, E.G. et al. (2009) Genomewide association studies of stroke. N. Engl. J. Med., 360, 1718-1728.
4. Gretarsdottir, S., Thorleifsson, G., Manolescu, A., Styrkarsdottir, U., Helgadottir, A., Gschwendtner, A., Kostulas, K., Kuhlenbäumer, G., Bevan, S., Jonsdottir, T. et al. (2008) Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann. Neurol., 64, 402-409.
5. Rosamond, W.D., Folsom, A.R., Chambless, L.E., Wang, C.H., McGovern, P.G., Howard, G., Copper, L.S. and Shahar, E. (1999) Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke, 30, 736-743.
6. Sacco, R.L., Adams, R., Albers, G., Alberts, M.J., Benavente, O., Furie, K., Goldstein, L.B., Gorelick, P., Halperin, J., Harbaugh, R. et al. American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology, Intervention; American Academy of Neurology (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation, 113, e409-e449.
7. Jerrard-Dunne, P., Cloud, G., Hassan, A. and Markus, H.S. (2003) Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke, 34, 1364-1369.
8. Kubo, M., Hata, J., Ninomiya, T., Matsuda, K., Yonemoto, K., Nakano, T., Matsushita, T., Yamazaki, K., Ohnishi, Y., Saito, S. et al. (2007) A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat. Genet., 39, 212-217.
9. Hata, J., Matsuda, K., Ninomiya, T., Yonemoto, K., Matsushita, T., Ohnishi, Y., Saito, S., Kitazono, T., Ibayashi, S., Iida, M. et al. (2007) Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Hum. Mol. Genet., 16, 630-639.
10. Rossman, K.L., Der, C.J. and Sondek, J. (2005) GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell. Biol., 6, 167-180.
11. Loirand, G., Scalbert, E., Bril, A. and Pacaud, P. (2008) Rho exchange factors in the cardiovascular system. Curr. Opin. Pharmacol., 8, 174-180.
12. Bos, J.L., Rehmann, H. and Wittinghofer, A. (2007) GEFs and GAPs: critical elements in the control of small G proteins. Cell, 129, 865-877.
13. Nagase, T., Kikuno, R., Hattori, A., Kondo, Y., Okumura, K. and Ohara, O. (2000) Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res., 7, 347-355.
14. Yoshizawa, M., Sone, M., Matsuo, N., Nagase, T., Ohara, O., Nabeshima, Y. and Hoshino, M. (2003) Dynamic and coordinated expression profile of dbl-family guanine nucleotide exchange factors in the developing mouse brain. Gene Expr. Patterns, 3, 375-381.
15. Verhoeven, K., De Jonghe, P., Van de Putte, T., Nelis, E., Zwijsen, A., Verpoorten, N., De Vriendt, E., Jacobs, A., Van Gerwen, V., Francis, A. et al. (2003) Slowed conduction and thin myelination of peripheral nerves associated with mutant rho guanine-nucleotide exchange factor 10. Am. J. Hum. Genet., 73, 926-932.
16. Kovacs, P., Stumvoll, M., Bogardus, C., Hanson, R.L. and Baier, L.J. (2006) A functional Tyr1306Cys variant in LARG is associated with increased insulin action in vivo. Diabetes, 55, 1497-1503.
17. Fu, M., Sabra, M.M., Damcott, C., Pollin, T.I., Ma, L., Ott, S., Shelton, J.C., Shi, X., Reinhart, L., O'Connell, J. et al. (2007) Evidence that Rho guanine nucleotide exchange factor 11 (ARHGEF11) on 1q21 is a type 2 diabetes susceptibility gene in the Old Order Amish. Diabetes, 56, 1363-1368.
18. Wang, L., Hauser, E.R., Shah, S.H., Pericak-Vance, M.A., Haynes, C., Crosslin, D., Harris, M., Nelson, S., Hale, A.B., Granger, C.B. et al. (2007) Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am. J. Hum. Genet., 80, 650-663.
19. Etienne-Manneville, S. and Hall, A. (2002) Rho GTPases in cell biology. Nature, 420, 629-635.
20. Loirand, G., Guérin, P. and Pacaud, P. (2006) Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res., 98, 322-334.
21. Ming, X.F., Barandier, C., Viswambharan, H., Kwak, B.R., Mach, F., Mazzolai, L., Hayoz, D., Ruffieux, J., Rusconi, S., Montani, J.P. et al. (2004) Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation, 110, 3708-3714.
22. Stamatovic, S.M., Keep, R.F., Kunkel, S.L. and Andjelkovic, A.V. (2003) Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J. Cell. Sci., 116, 4615-4628.
23. Sauzeau, V., Le Mellionnec, E., Bertoglio, J., Scalbert, E., Pacaud, P. and Loirand, G. (2001) Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ. Res., 88, 1102-1104.
24. Rikitake, Y. and Liao, J.K. (2005) Rho GTPases, statins, and nitric oxide. Circ. Res., 97, 1232-1235.
25. National Institute of Neurological Disorders and Stroke (1990) Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke, 21, 637-676.
26. Adams, H.P. Jr, Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L. and Marsh, E.E. III (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24, 35-41.
27. Cerebral Embolism Task Force (1986) Cardiogenic brain embolism. Arch. Neurol., 43, 71-84.
28. Nakamura, Y. (2007) The BioBank Japan Project. Clin. Adv. Hematol. Oncol., 5, 696-697.
29. Ohnishi, Y., Tanaka, T., Ozaki, K., Yamada, R., Suzuki, H. and Nakamura, Y. (2001) A high-throughput SNP typing system for genome-wide association studies. J. Hum. Genet., 46, 471-477.
30. Kobayashi, S., Shirai, T., Kiyokawa, E., Mochizuki, N., Matsuda, M. and Fukui, Y. (2001) Membrane recruitment of DOCK180 by binding to PtdIns(3,4,5)P3. Biochem. J., 354, 73-78.
31. Reid, T., Furuyashiki, T., Ishizaki, T., Watanabe, G., Watanabe, N., Fujisawa, K., Morii, N., Madaule, P. and Narumiya, S. (1996) Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J. Biol. Chem., 271, 13556-13560.
32. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.